Weight loss drugs show potential to reduce early death risk in heart patients, study reveals
A new study has found that GLP-1 agonists, commonly used for weight loss, can significantly reduce the risk of hospitalization or early death in heart patients, particularly those with heart failure and obesity. The research, conducted by Mass General Brigham, examined real-world data from over 90,0... [More info]